Xinjiang Chalkis Co Ltd

Zhongji Health (000972) disclosed its 2026 semi-annual report on August 29. In the first half of the year, it achieved total operating revenue of 197 million yuan, down 19.65 percent year on year. Net profit attributable to the parent company was a loss of 65.919 million yuan, compared with a loss of 74.7031 million yuan in the same period last year. Net profit after deducting non-recurring items was a loss of 74.66 million yuan, compared with a loss of 79.3333 million yuan a year earlier. Net cash flow from operating activities was 127 million yuan, compared with minus 101 million yuan in the prior-year period. Basic earnings per share were minus 0.0855 yuan. The company's main business is the research, development, manufacturing and sales of bulk-packaged tomato paste, small-packaged tomato products, lycopene soft capsules and other products. As of the end of the first half, the company's inventory decreased by 65.73 percent from the end of last year, prepayments increased by 260.53 percent, short-term borrowings decreased by 20.82 percent, and contract liabilities decreased by 39.28 percent.

Chalkis Health released its 2026 interim report. During the reporting period, the company's total operating revenue was 197 million yuan, and net profit attributable to the parent company was a loss of 65.919 million yuan, a reduction in loss of 8.7841 million yuan compared with the same period last year. Net cash inflow from operating activities was 127 million yuan, an increase of 228 million yuan year-on-year. The company's asset-liability ratio was 104.13%, down 2.66 percentage points year-on-year; gross margin was negative 19.81%; diluted earnings per share was negative 0.09 yuan, an increase of 0.01 yuan year-on-year. Total asset turnover was 0.18 times, up 12.99% year-on-year; inventory turnover was 1.02 times, up 212.38% year-on-year. The number of shareholders was 22,600, and the top ten shareholders held 43.04% of the total share capital.

Zhongji Health announced that the interim administrator has applied to the Sixth Division Intermediate Court to extend the pre-reorganisation period for the company and its subsidiary Red Tomato by three months to 28 October 2026. The reasons for the application include the need for supplementary evidence for some creditor claims, ongoing audit and valuation work, a pre-reorganisation plan still under formulation, and the requirement to complete relevant approval procedures for the reorganisation. On 27 July, the company and Red Tomato received a notice from the Sixth Division Intermediate Court confirming the extension decision.